Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection

New York University Langone Medical Center, New York

Frontier Clinical Research, LLC, Uniontown

TruCare Internal Medicine and Infectious Diseases, DuBois

Anne Arundel Health System Research Insitute, Annapolis

Infectious Disease Associates of Central Virginia Infectious Disease, Lynchburg

Southeastern Research Center, Winston-Salem

Clinical Research of Gastonia, Gastonia

University of Florida, Gainesville

Guardian Angel Research Center, Tampa

Innovative Research of West Florida, Clearwater

Gastro Florida, Clearwater

Toledo Institute of Clinical Research Inc, Toledo

Covenant HealthCare, Saginaw

Mayo Clinic, Rochester

NEA Baptist Clinic, Jonesboro

Clinrx Research Joseph INC, Plano

Texas Centers for Infectious Disease Associates, Fort Worth

Advanced Clinical Research-Be Well MD, Cedar Park

Phoenix Clinical, LLC, Phoenix

Mayo Clinic, Clinical Studies Unit, Phoenix

Alliance Research Institute, Canoga Park

Ventura Clinical Trials, Ventura

University of California, Davis Medical Center, Sacramento

Seattle Infectious Disease Clinic, Seattle

Advanced Clinical Research-Spokane Gastroenterology, Spokane

Medical Research Center of Connecticut, LLC, Hamden

Tufts Medical Center, Boston

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

Foothills Medical Centre - Microbial Health Clinic, Calgary

CARe Clinic, Red Deer

Moncton Hospital, Moncton

St. Joseph's Healthcare Hamilton, Hamilton

Viable Clinical Research, Scarborough Village

Q&T Research Chicoutimi, Chicoutimi

CHU de Québec-Université Laval, Québec

Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-, Trois-Rivières